Shanghai Competitors

688293 Stock   42.98  0.20  0.47%   
Shanghai OPM Biosciences competes with Industrial, China Construction, Agricultural Bank, Bank of China, and PetroChina; as well as few others. The company operates under Biotechnology sector and is part of Health Care industry. Analyzing Shanghai OPM competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Shanghai OPM to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Shanghai OPM Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Shanghai OPM competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
36.1141.4246.73
Details
Intrinsic
Valuation
LowRealHigh
27.2432.5547.28
Details
Naive
Forecast
LowNextHigh
36.6041.9147.22
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
40.5143.5246.54
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Shanghai OPM. Your research has to be compared to or analyzed against Shanghai OPM's peers to derive any actionable benefits. When done correctly, Shanghai OPM's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Shanghai OPM Biosciences.

Shanghai OPM Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Shanghai OPM and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Shanghai and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Shanghai OPM Biosciences does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Shanghai Stock performing well and Shanghai OPM Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Shanghai OPM's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
601398  1.27  0.06 (0.06)(0.03) 1.58 
 2.83 
 8.14 
601939  1.34  0.09 (0.04)(0.13) 1.76 
 3.32 
 8.64 
601288  1.31  0.05 (0.05)(0.07) 1.97 
 3.21 
 8.24 
601988  1.23  0.10 (0.03)(0.20) 1.51 
 2.67 
 7.70 
601857  1.49 (0.06) 0.00  0.23  0.00 
 3.43 
 17.17 
600036  1.56  0.29  0.05 (0.37) 1.72 
 4.65 
 13.83 
600938  1.59 (0.02) 0.00  0.16  0.00 
 3.25 
 16.49 
600941  1.00  0.03 (0.09)(0.04) 1.18 
 2.05 
 8.38 
601328  1.35 (0.03) 0.00  0.19  0.00 
 3.26 
 10.82 
601658  1.46  0.19  0.01 (0.31) 1.79 
 3.49 
 9.13 

Cross Equities Net Income Analysis

Compare Shanghai OPM Biosciences and related stocks such as Industrial and Commercial, China Construction Bank, and Agricultural Bank Net Income Over Time
201020112012201320142015201620172018201920202021202220232024
601398277.1 B277.1 B277.1 B277.1 B277.1 B277.1 B278.2 B286 B297.7 B312.2 B315.9 B348.3 B360.5 B364 B347.1 B
601939228.1 B228.1 B228.1 B228.1 B228.1 B228.1 B231.5 B242.3 B254.7 B266.7 B271.1 B302.5 B323.9 B332.7 B299.9 B
60128894.9 B121.9 B145.1 B166.3 B179.5 B180.6 B183.9 B193 B202.8 B212.1 B215.9 B241.2 B259.1 B269.4 B209.4 B
601988170.8 B170.8 B170.8 B170.8 B170.8 B170.8 B164.6 B172.4 B180.1 B187.4 B192.9 B216.6 B227.4 B231.9 B213.2 B
60185719.2 B19.2 B19.2 B19.2 B19.2 B35.5 B7.9 B22.8 B52.6 B45.7 B19 B92.2 B149.4 B161.1 B169.2 B
6000366.8 B36.1 B45.3 B51.7 B55.9 B57.7 B62.1 B70.2 B80.6 B92.9 B97.3 B119.9 B138 B146.6 B153.9 B
60093861 B61 B61 B61 B61 B61 B61 B61 B61 B61 B25 B70.3 B141.7 B163 B82 B
600941B125.9 B129.3 B121.7 B109.3 B108.5 B108.7 B114.3 B117.8 B106.6 B107.8 B116.1 B125.5 B131.8 B91.7 B
6013289.2 B50.7 B58.4 B62.3 B65.8 B66.5 B67.2 B70.2 B73.6 B77.3 B78.3 B87.6 B92.1 B92.7 B62.7 B
60165839.8 B39.8 B39.8 B39.8 B39.8 B39.8 B39.8 B47.7 B52.3 B60.9 B64.2 B76.2 B85.2 B86.3 B70.5 B

Shanghai OPM Biosciences and related stocks such as Industrial and Commercial, China Construction Bank, and Agricultural Bank Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Shanghai OPM Biosciences financial statement analysis. It represents the amount of money remaining after all of Shanghai OPM Biosciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Shanghai OPM Competitive Analysis

The better you understand Shanghai OPM competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Shanghai OPM's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Shanghai OPM's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
688293 601398 601939 601288 601988 601857 600036 600938 600941 601328
 0.47 
 42.98 
Shanghai
 0.33 
 6.07 
Industrial
 0.51 
 7.88 
China
 0.64 
 4.73 
Agricultural
 1.01 
 4.91 
Bank
 0.25 
 8.03 
PetroChina
 0.63 
 36.22 
China
 1.11 
 26.50 
CNOOC
 0.29 
 103.70 
China
 0.71 
 7.13 
Bank
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Return On Asset
Book Value Per Share
Total Asset
Target Price
Last Dividend Paid
Shares Owned By Institutions
Market Capitalization
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Shanghai OPM Competition Performance Charts

Five steps to successful analysis of Shanghai OPM Competition

Shanghai OPM's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Shanghai OPM Biosciences in relation to its competition. Shanghai OPM's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Shanghai OPM in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Shanghai OPM's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Shanghai OPM Biosciences, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Shanghai OPM position

In addition to having Shanghai OPM in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Consumer Staples ETFs Thematic Idea Now

Consumer Staples ETFs
Consumer Staples ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Consumer Staples ETFs theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Staples ETFs Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Shanghai Stock

Shanghai OPM financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai OPM security.